TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$11.38M2013: -$17.85M2014: -$26.33M2015: $13.08M2016: $207.0K2017: $27.86M2018: $20.91M2019: $21.00M2020: $24.56M2021: $23.08M2022: -$10.91M2023: $7.30M2024: $133.03M2025: $83.05M$83.05M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$83.05M-37.6%
2024$133.03M+1721.4%
2023$7.30M+166.9%
2022-$10.91M-147.3%
2021$23.08M-6.0%
2020$24.56M+17.0%
2019$21.00M+0.4%
2018$20.91M-25.0%
2017$27.86M+13358.6%
2016$207.0K-98.4%
2015$13.08M+149.7%
2014-$26.33M-47.5%
2013-$17.85M-56.8%
2012-$11.38M—